跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADR-3
首页
药物
ADR-3
ADR-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of 3-substituted aryl oxindole in multidrug resistance tumor cells
申请人: INST OF HEMATOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES
优先权: 2009
CN
Pharmaceutical use of diacetyl diphenyl sulphone heptane in preventing and controlling chronic marrow-derived leukocythemia
申请人: WENZHOU MEDICAL COLLEGE
优先权: 2008
CN
Traditional Chinese medicine composition for treating mycotic stomatitis of children and application thereof
申请人: QINGPU CHINESE MEDICINE HOSPITAL
优先权: 2019
CN
New method for the preparation of 1,5-bis(4-hydroxy-3-metoxy-phenyl)-penta-1,4-dien-3-one and derivatives with antitumoral properties
申请人: SUAREZ JOSE A Q
优先权: 2002
US
2 件公开
石墨烯量子点在制备抑制细胞多药耐药基因的药物中的应用
申请人: 华东理工大学
优先权: 2016
CN
Small-particle-size anti-tumor nano-drug system and preparation method thereof
申请人: BEIJING HOSPITAL
优先权: 2019
CN
6-(吡啶-3-基)喹唑啉-4(3H)-酮类衍生物及其制备和应用
申请人: 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室)
优先权: 2021
CN
Preparation method and application of zinc organic framework drug-loading system entrapping rapamycin
申请人: FIRST AFFILIATED HOSPITAL OF ANHUI MEDICAL UNIV
优先权: 2019
CN
药物
反馈